FCG
STIM icon

Fielder Capital Group’s Neuronetics STIM Stock Holding History

Fielder Capital Group’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8K Buy
22,903
+46
+0.2% +$67 0.01% 301
2026
Q1 		$33.1K Buy
22,857
+60
+0.3% +$95 0.01% 290
2025
Q4 		$31.5K Hold
22,797
– – 0.01% 277
2025
Q3 		$62.2K Hold
22,797
– – 0.01% 267
2025
Q2 		$79.6K Hold
22,797
– – 0.02% 242
2025
Q1 		$83.9K Hold
22,797
– – 0.02% 222
2024
Q4 		$36.7K Hold
22,797
– – 0.01% 211
2024
Q3 		$17.3K Hold
22,797
– – 0.01% 215
2024
Q2 		$41K Hold
22,797
– – 0.02% 195
2024
Q1 		$109K Hold
22,797
– – 0.05% 171
2023
Q4 		$66.1K Buy
+22,797
New +$36K 0.04% 145

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fielder Capital Group's STIM Position: Q2 2026 in Review

Fielder Capital Group increased its Neuronetics (STIM) stake by 0.2% in Q2 2026, buying an estimated $67 and bringing the position to 22,903 shares worth $29.8K. The position accounts for 0.01% of the portfolio, ranked #301.

Fielder Capital Group first reported a position in STIM in Q4 2023 and has held it in 11 quarters since. The position peaked at $109K in Q1 2024. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Fielder Capital Group held 22,903 shares of Neuronetics worth $29.8K as of Q2 2026.
  • Fielder Capital Group bought 46 Neuronetics shares in Q2 2026, an estimated $67.
  • Neuronetics made up 0.01% of Fielder Capital Group's portfolio in Q2 2026, its #301 holding.
  • Fielder Capital Group first reported a position in Neuronetics in Q4 2023 and has held it in 11 quarters since.
  • Fielder Capital Group's Neuronetics position peaked at $109K in Q1 2024.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Fielder Capital Group's 13F filing for Q2 2026, filed 6 Aug 2026.